#RBQMLive
RBQMLive 2025 On-Demand
Keynote—Measuring the Impact: Quantifying the ROI of RBQM
Speakers: Ken Getz, Executive Director & Professor, Tufts CSDD; Abby Dirks, Data Scientist, Tufts CSDD
- Evaluate ROI using NPV analysis to quantify financial and operational impact
- Review the latest data modeling research with real-world data and case studies
- Explore how RBQM aligns with ICH E6(R3) guidelines to improve clinical trials
- Discover measurable benefits of RBQM, making a strong case for adoption
- Get actionable strategies for integrating RBQM into clinical trial operations
Panel—Decoding ICH E6(R3): From Principles to Practice
Participants: Cris McDavid, Senior Director, Global Clinical Operations, Parexel; Dawn Anderson, Managing Director, Life Sciences Clinical Transformation Leader, Deloitte; Leonie Christianson, Business Consultant, Syneos Health
- Understand updated ICH E6(R3) guidelines and their impact on trial oversight
- Hear how Sponsors and CROs are adapting quality systems to the guidelines
- See how RBQM and integrated data review improve data quality and reduce risk
- Discover practical approaches with change management and digital tools
- Learn how Sponsors, CROs, and regulators are collaborating to meet evolving expectations
Harnessing AI for Risk Based EVERYTHING: Current Innovations & Future Directions
Speaker: Drew Garty, Chief Technology Officer, Veeva
- Explore how AI improves protocol design, risk identification, and trial efficiency
- Learn from case studies showcasing AI-driven RBQM in practice
- Manage the shift to AI-powered RBQM with engagement and training
- Gain a forward-looking view of how to prepare for upcoming innovations and methodologies
